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2Introduction
De-novo bile acid (BA) formation is the major pathway in mammals for excretion
of cholesterol (for review, see [1]). BAs are synthesized from cholesterol in the liver
and are conjugated to either glycine or taurine before secretion into the bile. This
conjugation (or amidation) plays several important biological roles: it promotes
secretion of BAs and cholesterol into bile, and increases the detergent properties of
BAs in the intestine, which facilitates lipid and vitamin absorption. BAs are
deconjugated by the intestinal flora and recycled back to the liver for reconjugation.
The initial steps in the biosynthesis of BAs involve oxidative modifications of the
cholesterol backbone and side-chain to form dihydroxycholestanoic acid (DHCA)
and trihydroxycholestanoic acid (THCA). DHCA and THCA are activated to their
corresponding CoA-esters, followed by b-oxidative cleavage in peroxisomes to
form chenodeoxycholoyl-CoA (CDCA-CoA) and choloyl-CoA (CA-CoA)
respectively, which are substrates for conjugation to glycine or taurine [2-5]. This
conjugation (or amidation) is catalyzed by the enzyme bile acid-CoA:amino acid N-
acyltransferase (BACAT), an enzyme recently implicated in inheritance of familial
hypercholanemia [6]. Recent data show that BACAT activity is present both in
peroxisomes and in cytosol [5], suggesting the existence of two BACAT enzymes. It
has been proposed that while the peroxisomal enzyme conjugates de-novo
synthesized BAs, the cytosolic enzyme has a function in conjugating BAs recycled
from the intestine via the enterohepatic circulation to the liver. Mihalik et al also
recently suggested the existence of two pathways for conjugation of BAs. They
showed that human very long-chain acyl-CoA synthetase (VLCS), present in
peroxisomes and the endoplasmic reticulum, primarily activates THCA, which is a
precursor for de-novo synthesis of bile acids. In contrast, a homologue of this
enzyme (VLCS-H2) located in the endoplasmic reticulum and referred to as bile
acid-CoA synthetase (BACS), activates mainly BAs [7]. It was therefore suggested
that BACS activates recycled BAs for conjugation by BACAT in the cytosol.
However, to date only one BACAT enzyme has been identified and characterized.
The enzyme has been purified from several species such as rat [8], bovine [9],
domestic fowl [10], fish [11] and human [12], and partially purified from pig [13],
canine [14], guinea pig and rabbit [15]. Molecular cloning of the human BACAT
showed that the enzyme can conjugate bile acids to both glycine and taurine [16].
3Recently it has been shown that recombinantly expressed human BACAT can also
conjugate fatty acyl-CoAs to glycine [17].
We have recently identified and characterized a family of highly homologous acyl-
CoA thioesterases, referred to as type-I acyl-CoA thioesterases, with putative
localizations in peroxisomes (PTE-Ia, PTE-Ib and PTE-Ic), mitochondria (MTE-I)
and cytosol (CTE-I) [18, 19]. Database searches and subsequent sequence
alignments revealed that these acyl-CoA thioesterases show sequence homology
only to BACAT from rat [20], mouse [21] and human [16], with a sequence identity
of 40-45% to the type-I acyl-CoA thioesterases. Acyl-CoA thioesterases hydrolyze
acyl-CoAs to non-esterified fatty acids and CoASH. By preserving a balance of
acyl-CoA, free fatty acids and CoASH in the cell, acyl-CoA thioesterases directly,
and indirectly via gene regulation, influence numerous cellular processes involved
in lipid metabolism, for example b-oxidation and esterification of fatty acids (for
review, see [22]).
We have now identified two new enzymes related to both BACAT and the type-I
acyl-CoA thioesterases. These gene products show approximately 55% sequence
identity to the mouse BACAT and approximately 95% sequence identity to
eachother. Both these proteins contain a peroxisomal type-I targeting signal of -
SKL, which targets the proteins to peroxisomes. We suggest that one of these
proteins could be a novel peroxisomal BACAT.
Experimental procedures
Preparation and characterization of mouse liver subcellular fractions
Homogenates were prepared from SV/129 male mouse fresh liver as described
[23]. Purified peroxisomes were isolated by density gradient centrifugation of
light-mitochondrial fractions prepared from homogenates of pooled livers from
untreated and WY-14,643 treated mice as described [24]. Bile acid-CoA:amino acid
N-acyltransferase activity was measured as previously described (3).
Antibody production and affinity purification
A peptide with the amino acid sequence NH2-CAAQEHSWKEIQKFLK-COOH,
based on the mouse BACAT amino acid sequence [25], (with a cysteine added at
the NH2-terminal end for coupling of the peptide) was synthesized and used to
4raise antisera in rabbits (Sigma Genosys). The BACAT antibody was purified from
rabbit serum using a peptide affinity column prior to Western blotting.
Western blot analysis
Western blot analysis was performed as described previously [26] using the BACAT
antibody and a horseradish peroxidase conjugated anti-rabbit IgG secondary antibody. The
signal was detected using enhanced chemiluminescence (ECL) (Amersham Life Science,
Arlington Heights, IL) and the filters were exposed to X-ray film.
Northern blot analysis
Total RNA was prepared from mouse livers using QuickPrepR total RNA
extraction kit (Amersham Pharmacia Biotech, Uppsala, Sweden), and Northern
blot analysis was carried out as described previously [26]. The filter was probed
with a 32P-labelled full-length cDNA probe for the newly identified mouse
peroxisomal BACAT and the blot was exposed to X-ray film at –70°C.
Localization of mouse BACAT using green fluorescent fusion protein (GFP) -
The mouse BACAT open reading frame [25] was cloned into the pcDNA3.1/NT-
GFP vector (Invitrogen), in-frame with the GFP at the N-terminal end. Site-
directed mutagenesis was carried out using the QuikChange‰ Site Directed
Mutagenesis kit (Stratagene), to mutate the C-terminal -SQL to –SKL. The
nucleotide change was verified by sequencing. The open reading frame of one of
the newly identified peroxisomal BACAT enzymes, ending –SKL, was cloned in-
frame into the pcDNA3.1/NT-GFP vector (Invitrogen) with the GFP at the N-
terminal end. Human skin fibroblasts from a healthy control and a Zellweger
patient were grown as described [27]. Fibroblasts were transfected with 10 mg  of
BACAT/NT-GFP plasmids using Calcium Phosphate method as described, but
without staining of the nucleus with Hoescht 33342 [27].
Results
Mouse BACAT is regulated by treatment with WY-14,643
BACAT activity was measured in both cytosolic and peroxisomal fractions from
both untreated mouse liver and those treated with the peroxisome proliferator
5WY-14,643. In the cytosolic fraction, BACAT activity was approximately 20
nmol/min/mg and was unchanged by treatment with WY-14,643 (Fig. 1A).
However, in peroxisomal fractions, the specific activity of BACAT was
approximately 100 nmol/min/mg and was reduced to approximately 7
nmol/min/mg following treatment with WY-14,643. Western blot analysis using
an antibody to the C-terminal end of the published mouse BACAT [25] showed
that the BACAT protein in cytosol was also unchanged following WY-14,643
treatment, however in peroxisomes, BACAT protein was severely decreased
following WY-14,643 treatment (Fig. 1B). This suggested the existence of two
distinct BACAT enzymes, one in cytosol, which is not regulated by fibrate
treatment, and one in peroxisomes that is highly downregulated via fibrates.
Mouse BACAT is a cytosolic enzyme
The human and mouse BACAT enzymes previously cloned [25, 28] contain a C-
terminal -SQL which is a variant of the well-characterized consensus peroxisomal
type-1 targeting signal (PTS1) of -SKL (serine, lysine, leucine), the latter which has
been shown to target proteins to peroxisomes [29]. To establish whether BACAT
is localized in peroxisomes, we cloned the mouse BACAT in-frame with GFP at
the N-terminal end, which leaves the C-terminal -SQL sequence accessible. The
plasmid encoding the mouse BACAT-GFP fusion protein was transfected into
human skin fibroblasts, and by using immunofluorescence microscopy for
detection of a Tritc labelled anti-GFP antibody, mouse BACAT showed a diffuse
GFP expression, with no sign of a punctate pattern, indicative of a cytosolic
localization (Fig. 2A). We also mutated the C-terminal -SQL to -SKL, the
consensus PTS1 targeting signal, and transfected this construct into human skin
fibroblasts. Immunofluorescence microscopy showed that the mouse BACAT-SKL
mutant was translocated to peroxisomes based on the punctate pattern (Fig. 2B).
Similar results were obtained by transfection of the human BACAT-GFP fusion
plasmid [17].
Identification of new candidate genes for peroxisomal BACAT
Database searches were carried out using the open reading frame for the mouse
BACAT [25] and type-I acyl-CoA thioesterases [18] (www.ncbi.nih.gov). Two
candidate genes were identified, one of which is localized on the same
6chromosome as the mouse BACAT previously cloned, mouse chromosome 4.
These gene products encode proteins of approximately 46 kDa, and show about
55% sequence identity to the mouse BACAT. The 2 newly identified putative
BACAT enzymes show approximately 95% sequence identity to eachother.
Characterization of the new peroxisomal BACAT enzymes
The putative peroxisomal BACAT enzymes both contain an –SKL at their
carboxyterminal ends, which should result in localization of these proteins in
peroxisomes. To establish whether one of these BACAT proteins is localized in
peroxisomes, we cloned the putative peroxisomal BACAT in-frame with GFP at
the N-terminal end, which leaves the C-terminal -SKL sequence accessible. The
GFP fusion protein plasmid was transfected into human skin fibroblasts from a
control and a Zellweger patient, who are unable to import peroxisomal matrix
proteins. Using immunofluorescence microscopy for detection of a Tritc labelled
anti-GFP antibody, the peroxisomal BACAT showed a distinct punctate pattern of
expression, indicative of a peroxisomal localization (Fig. 3A). In Zellweger
fibroblasts, the GFP fusion protein showed a diffuse GFP expression, with little
sign of a punctate pattern, indicative of a cytosolic localization (Fig. 3B)
Northern blot analysis using a full-length probe to one of the newly identified
putative peroxisomal BACAT enzymes (which will recognize both peroxisomal
BACAT transcripts due to the very high degree of sequence identity to eachother
(95%)) showed that these enzymes are mainly expressed in liver, kidney and
gallbladder, with one of these enzymes also weakly expressed in proximal and
distal intestine and spleen (Fig. 4).
Discussion
There are two pathways for conjugation of bile acids to glycine or taurine in the
cell. BACAT activity is present in peroxisomes for amidation (conjugation) of de-
novo synthesized bile acids, while a cytosolic BACAT enzyme functions in
amidation of recycled bile acids [5]. The specific BACAT activity from human [5]
and mouse liver [24] is much higher in the peroxisomal fraction compared to the
cytosolic fraction. Based on the findings that BACAT is mainly cytosolic in mouse
7(this study) and human [17], it is proposed that the function of the previously
characterized BACAT is in the conjugation of recycled bile acids, and it was
predicted that there exists another peroxisomal BACAT enzyme that conjugates
de-novo synthesized bile acids. Conjugation of bile acids is believed to occur
mainly in the liver. In mouse, the cytosolic BACAT enzyme is strongly expressed
in liver, gallbladder and intestine (both proximal and distal), compatible with an
important function in amidation of bile acids and protection of gastro-intestinal
mucosal cells from accumulation of free bile acids [17]. Recycled free bile acids
need to be activated to the corresponding CoA-ester prior to conjugation to
glycine or taurine by the BACAT enzyme. Recent studies have shown that bile
acids are mainly activated by BACS, a microsomal bile acid-CoA synthetase,
while THCA, a precursor of de-novo bile acid synthesis in peroxisomes, is mainly
activated by very long-chain acyl-CoA synthetase (VLCS) located in the
peroxisomal and endoplasmic reticulum membranes [7, 30]. Pircher et al have
now shown that both BACAT and BACS are target genes of the farnesoid X
receptor (FXR), the key nuclear receptor involved in regulation of bile acid
sythnesis, consolidating their function in conjugation of bile acids [31].
There has been some controversy during the past years concerning the subcellular
localization of BACAT. Experiments carried out on homogenates from frozen
human liver showed BACAT to be cytosolic, although it was suggested that
freezing and thawing of the liver may have caused lysis of cellular organelles
leading to a redistribution of BACAT activity from the peroxisomes to the cytosol
[13]. Immunohistochemical analysis showed that BACAT was localized in the
cytoplasm of hepatocellular carcinoma cells as well as the hepatocytes and the
bile duct cells in human liver [32]. More recently it has been shown that BACAT
activity is present both in cytosolic and peroxisomal fractions [5]. Although both
the human and mouse BACAT proteins contain a variant (-SQL) [16, 25] of the
type I peroxisomal targeting signal (PTS1) –SKL, our data shows that the mouse
BACAT protein is mainly cytosolic. Mutation of the -SQL sequence to -SKL results
in the translocation of the protein from the cytosol, exclusively to peroxisomes.
The human BACAT also shows a cytosolic localization and mutation of the -SQL
to –SKL results in a peroxisomal localization [17]. Therefore the previously cloned
mouse [25] and human [28] BACAT enzymes are cytosolic, which suggests that
there exists a further peroxisomal BACAT responsible for the conjugation of de-
novo synthesized bile acids in peroxisomes.
8Recent data from Inoue et al [33] further supported the hypothesis for a second
peroxisomal BACAT enzyme, using the null mouse model of the hepatocyte
nuclear factor 4a (HNF-4a). The HNF-4a  is a nuclear receptor that has an
important role in regulating expression of many liver-specific genes. In the HNF-
4a-null mouse model, expression of BACAT is almost undetectable in mouse liver
using Northern blot analysis, suggesting that this receptor has an important
function in maintaining expression of BACAT. A HNF-4a binding site was indeed
demonstrated in the promotor of the BACAT gene [33]. These animals showed an
altered bile acid pattern with increased unconjugated bile acids in serum. They
also showed an increase in glycine-conjugated bile acids. It has been shown that
the mouse BACAT does not contain glycine conjugating activity [25], therefore
this suggested that there may be a further unidentified BACAT gene which is
activated in the HNF-4a-null mouse model, and which can conjugate bile acids to
glycine.
Identification of a putative new peroxisomal BACAT
BACAT shows approximately 40-45% sequence identity to a family of enzymes
known as acyl-CoA thioesterases. These enzymes have been identified in several
cellular compartments such as cytosol, mitochondria and peroxisomes (for review
see [22]. Database searches using both BACAT and acyl-CoA thioesterase
sequences, identified two further genes in mouse which are related to both
BACAT and acyl-CoA thioesterases. The products of these two genes show
approximately 55% sequence identity to BACAT and are expressed in liver,
kidney, gallbladder and weakly in proximal and distal intestine. Both these
enzymes contain the classical peroxisomal type I targeting signal of –SKL at their
carboxyterminal ends, which targets the proteins to peroxisomes. We therefore
suggest that one of these enzymes could be the new candidate peroxisomal
BACAT. We are currently expressing these gene products as recombinant
proteins to examine if they have bile acid conjugating activity. However, we have
encountered problems to obtain soluble protein in E. coli, but are currently
working on other expression systems.
In conclusion, we have provided evidence for a novel peroxisomal BACAT, which
may conjugate de-novo synthesized bile acids in peroxisomes.
9Figure legends
 Fig. 1: Differential regulation of peroxisomal and cytosolic BACAT activity and
 protein following treatment with WY-14,643. (A) Cytosol and purified
 peroxiomes were isolated from pooled livers from untreated (black bars) and
 WY-14,643 treated (grey bars) mice. BACAT activity was measured in each
 fraction as described in Experimental Procedures. Fig. adapted from [24]. (B)
Western blot analysis of protein isolated from cytosol (38 mg) or purified
peroxisomes (5 mg) from control (untreated) or WY-14,643 treated mouse liver,
using an affinity purified antibody to mouse BACAT.
Fig. 2: Mouse BACAT is localized in cytosol. The previously cloned mouse
BACAT [25] was expressed as a green fluorescent fusion protein (with the C-
terminal sequence –SQL) and the same plasmid mutated in the C-terminal
to –SKL. Human skin fibroblasts were transfected with these BACAT-GFP
plasmids and the cells were incubated with a rabbit GFP antibody followed by a
CY3 conjugated affinity purified donkey anti-rabbit IgG and examined by
immunofluorescence microscopy. A; mouse BACAT (-SQL), B; mouse BACAT-
SKL mutant.
Fig. 3: The newly identified peroxisomal BACAT is localized in peroxisomes.
The open reading frame of the putative peroxisomal BACAT was cloned as a
green fluorescent fusion protein and human skin fibroblasts from a healthy
control and a Zellweger patient were transfected with this plasmid. The cells were
incubated with a rabbit GFP antibody followed by a CY3 conjugated affinity
purified donkey anti-rabbit IgG and examined by immunofluorescence
microscopy. (A) Control fibroblasts (B) Zellweger fibroblasts.
Fig. 4: Tissue expression of peroxisomal BACAT. Northern blot analysis was
carried out on 20 mg of total RNA from SV/129 male mouse tissues. The filter was
incubated with a 32P-labelled mouse peroxisomal BACAT cDNA probe as
described in Experimental Procedures. BAT: brown adipose tissue, WAT: white
adipose tissue.
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